Key facts
- Medicilio’s last known valuation is $4.3M (Feb 2021).
- It has raised $5.7M; the latest was Later Stage VC ($20K) in Apr 2025.
- Notable investors include LIFTT, Alecla7, AVM Gestioni SGR, Heal Capital, Heroes — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Medicilio
- ·The full record, as it builds
Funding rounds
No funding rounds for Medicilio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medicilio
Operator of home-based healthcare services designed for delivering medical exams, diagnostics, and remote patient monitoring directly to residences. The company's platform offers in-home diagnostic procedures, telemonitoring of vital signs using certified medical devices, and coordinated care pathways, enabling healthcare providers and institutions to extend patient care beyond clinical settings while maintaining continuity, accessibility, and timely reporting for individuals with limited mobility or chronic conditions.
- Sector
- Healthcare
- HQ
- Milan, Italy
- Founded
- 2020
- Employees
- 39
- Website
- medicilio.it/
- Ownership
- Privately Held (backing)
Medicilio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medicilio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medicilio in its N-PORT filings yet. We sweep new filings monthly.